ANRO vs NVST · $60.1M cap vs P/E 56, rev $1.44B
Alto Neuroscience, Inc. (ANRO) versus Envista Holdings Corp (NVST) — a side-by-side from cached financials, not a winner call.
Alto Neuroscience, Inc. (ANRO) is a biotechnology company listed on US.
Envista Holdings Corp (NVST) is a medical instruments & supplies company listed on US.
ANRO does not have a complete income-statement cache yet.
Latest reported NVST revenue for 2026-07-03 was $1.44B. Net income was $92.4M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
ANRO currently screens at market cap $60.1M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
Not investment advice. Open the ANRO and NVST stock pages for the full models.
Not investment advice.